Connect with us

Politics

Lawmakers React To Sessions Anti-Marijuana Move

Published

on

A bipartisan collection of members of Congress and state officials are pushing back on U.S. Attorney General Jeff Sessions’s move to rescind Obama-era guidance that has generally allowed states to implement their own marijuana laws without federal interference.

Sen. Cory Gardner (R-CO):

Sen. Kirsten Gillibrand (D-NY):

Sen. Lisa Murkowski (R-AK):

Washington State Gov. Jay Inslee (D):

Colorado Gov. John Hickenlooper (D):

Massachusetts Cannabis Control Commission:

Congresswoman Nancy Pelosi (D-CA):

Sen. Chuck Schumer (D-NY):

Oregon Gov. Kate Brown (D):

Arkansas Gov. Asa Hutchinson (R):

Alaska Gov. Bill Walker (I):

“I remain committed to upholding the will of Alaskans on this issue, and maintaining our State’s sovereign rights to manage our own affairs while protecting federal interests.”

Colorado Attorney General Cynthia Coffman (R):

Congressman Denny Heck (D-WA):

Congressman Mike Coffman (R-CO):

Sen. Dan Sullivan (R-AK):

Today’s action by the Department of Justice — which contradicts previous statements by the President that this is an issue best left to the states, and adds new confusion and uncertainty for numerous states and communities — could be the impetus necessary for Congress to find a permanent legislative solution for states that have chosen to regulate the production, sale and use of marijuana. As we move forward, I will be examining new and existing legislative proposals and working to ensure the rights of Alaskans and the State of Alaska are protected.”

Congressman Don Young (R-AK):

“Today’s decision announced by the Department of Justice (DOJ) is a direct violation of states’ rights. Rolling back the Cole Memo without a responsible replacement to protect individuals and the states they live in is unacceptable.”

Congressman Carlos Curbelo (R-FL):

Sen. Bernie Sanders (I-VT):

Sen. Elizabeth Warren (D-MA):

Sen. Brian Schatz (D-HI):

Congressman Ted Lieu (D-CA):

Sen. Patrick Leahy (D-VT):

Sen. Jeanne Shaheen (D-NH):

Sen. Orrin Hatch (R-UT):

Congressman Jerrold Nadler (D-NY), Congresswoman Sheila Jackson Lee (D-TX) and Congressman Steve Cohen (D-TN):

“This change takes us in the wrong direction and is another step by the Trump Justice Department toward rolling back the sensible and more effective prosecution policies established by the Justice Department under President Obama. The Judiciary Committee should conduct hearings on these issues so that we may develop better strategies for preventing drug abuse and focusing the Justice Department’s efforts on those who pose the most serious threats to public safety.”

Congressman Dana Rohrabacher (R-CA):

Sen. Jeff Merkley (D-OR):

Massachusetts Gov. Charlie Baker (R):

North Dakota Gov. Doug Burgum (R):

We support states’ rights when deciding whether medical marijuana should be legalized, and North Dakota voters have spoken.”

Sen. Cory Booker (D-NJ):

Congressman Matt Gaetz (R-FL):

Pennsylvania Gov. Tom Wolf (D):

Congressman Rod Blum (R-IA):

California Attorney General Xavier Becerra (D):

Puerto Rico Gov. Ricardo Rosello (NPP):

Sen. Chris Van Hollen (D-MD):

Sen. Catherine Cortez Masto (D-NV):

Sen. Kamala Harris (D-CA):

Sen. Bob Casey (D-PA):

Sen. Ron Wyden (D-OR):

Sen. John Hoeven (R-ND):

States are really determining how this issue will be handled now and going forward, and I don’t think this policy decision will change that.”

Sen. Mark Warner (D-VA):

“It seems to be the absolute opposite direction from where our country’s headed.”

Congressman Keith Ellison (D-MN):

Congressman Kevin Cramer (R-ND):

Congress should act on this and make it clear that … this a states’ rights issue, that it should be up to states to determine whether they want to allow marijuana.”

Congresswoman Dina Titus (D-NV):

Congressman Jason Lewis (R-MN):

Congressman Scott Tipton (R-CO):

“The announcement by the Department of Justice is a drastic departure from the Attorney General’s previous commitment to Senator Cory Gardner during the confirmation process that he would uphold the Obama Administration’s treatment of marijuana enforcement and President Trump’s comments that he would leave it to the states. Furthermore it creates even greater confusion and uncertainty by leaving enforcement decisions up to federal prosecutors. The Department of Justice should provide guidance on enforcement of marijuana for states that have voted to legalize it. The people of Colorado voted to legalize marijuana in the state, and I am committed to defending the will of Coloradans.”

California Lt. Gov. Gavin Newsom (D):

Nevada Gov. Brian Sandoval (R):

Congressman Earl Blumenauer (D-OR):

Congresswoman Eleanor Holmes Norton (D-DC):

Congresswoman Barbara Lee (D-CA):

Congresswoman Tulsi Gabbard (D-HI):

Congressman Thomas Massie (R-KY):

Sen. Rand Paul (R-KY):

Sen. Dean Heller (R-NV):

Sen. Heidi Heitkamp (D-ND):

“I’m going to continue to follow this situation to see how it will impact our state, especially after North Dakotans made their voices heard and voted to legalize medical marijuana.”

Congressman Steve Cohen (D-TN):

Washington State Attorney General Bob Ferguson (D):

Sen. Patty Murray (D-WA):

Congressman Ro Khanna (D-CA):

Congressman Jared Polis (D-CO):

Sen. Chris Coons (D-DE):

Devoting our limited resources to prosecuting medical marijuana use that is permitted under Delaware state law is a poor allocation of federal time, money, and manpower that should be focused on more important things, such combating violent crime on our streets.”

Congressman Justin Amash (R-MI):

Congressman Beto O’Rourke (D-TX):

Congressman Adam Schiff (D-CA):

Congresswoman Chellie Pingree (D-ME):

Congressman Derek Kilmer (D-WA):

“This action by Attorney General Sessions would silence the voices of the majority of Washington state’s voters. No matter how you feel about the legalization of marijuana, this decision by the federal government to meddle in a state issue settled by public referendum is particularly troubling and would create tremendous uncertainty. It’s the wrong decision and is in direct conflict with the Attorney General’s long career of advocating for more autonomy for state and local governments.”

Congressman Seth Moulton (D-MA):

Congressman Darren Soto (D-FL):

Congressman Hank Johnson (D-GA):

Congressman Tim Walz (D-MN):

Congresswoman Nydia Velazquez (D-NY):

Congressman Hakeem Jeffries (D-NY):

Washington, D.C. Attorney General Karl Racine (D):

Nevada Attorney General Adam Laxalt (R):

Maryland Attorney General Brian Frosh (D):

Sen. Michael Bennet (D-CO):

Congressman Mark Takano (D-CA):

Congresswoman Pramila Jayapal (D-WA):

Connecticut Gov. Dannel Malloy (D):

“Especially during the midst of a national opioid crisis, medical marijuana provides an important alternative to opioids and is counted on for relief by 22,000 Connecticut residents. Rather than diverting critical federal resources and infringing on the will of the American people, Attorney General Sessions would do well to take a leaf out of Connecticut’s book, where our marijuana policies have allowed law enforcement professionals to focus on reducing violent crime, with demonstrated success. We will continue to follow Connecticut law regarding marijuana policy despite this short-sighted decision.”

Congresswoman Suzan DelBene (D-WA):

Congresswoman Suzanne Bonamici (D-OR):

Congresswoman Julia Brownley (D-CA):

Congressman Mike Thompson (D-CA):

Congressman Ed Perlmutter (D-CO):

Congressman Joe Crowley (D-NY):

Congressman Ryan Cosetllo (R-PA):

Congressman Ruben Gallego (D-AZ):

Massachusetts Attorney General Maura Healey (D):

Congresswoman Jacky Rosen (D-NV):

Congressman Peter Welch (D-VT):

Congressman Tom Garrett (R-VA):

Congresswoman Colleen Hanabusa (D-HI):

Congressman Adam Lowenthal (D-CA):

Congressman John Delaney (D-MD):

“The Cole Memo provided clear guidance to an otherwise conflicting situation. Revoking the Cole Memo will restore that confusion and undermines the will of the voters in several states.”

Congressman Ruben Kihuen (D-NV):

Congressman Adam Smith (D-WA):

Colorado Senate Democrats:

This post will be updated as more reactions come in.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Tom Angell is the editor of Marijuana Moment. A 15-year veteran in the cannabis law reform movement, he covers the policy and politics of marijuana. Separately, he founded the nonprofit Marijuana Majority. Previously he reported for Marijuana.com and MassRoots, and handled media relations and campaigns for Law Enforcement Against Prohibition and Students for Sensible Drug Policy. (Organization citations are for identification only and do not constitute an endorsement or partnership.)

Politics

Mitch McConnell Presses FDA Nominee On CBD And Hemp

Published

on

Senate Majority Leader Mitch McConnell (R-KY) met with the nominee to become the next Food and Drug Administration (FDA) commissioner on Wednesday and discussed the need for a regulatory framework for CBD products.

While there are few specific details available about their conversation, McConnell said he emphasized the importance of hemp legalization for Kentucky farmers and pointed out that those producers are also facing challenges given the lack of FDA regulations concerning CBD.

“I look forward to working closely with Dr. Hahn on several important issues for Kentucky,” McConnell said in a press release. “Like many Kentuckians who are taking advantage of hemp’s legalization, I am eager for FDA’s plans to create certainty for CBD products.”

The majority leader has previously pressed FDA to issue enforcement discretion guidance that prioritizes action against only CBD companies making especially unfounded medical claims about their products while allowing responsible businesses to continue to market their products as the agency continues to develop rules.

McConnell similarly raised his concerns about the importance of expediting CBD regulations during a separate meeting with Acting FDA Commissioner Ned Sharpless in June.

Stephen Hahn, the FDA nominee, was also pressed on CBD issues during a confirmation hearing on Wednesday. Sens. Jacky Rosen (D-NV) and Pat Roberts (R-KS) noted that there’s wide consumer interest in the cannabis products but stressed that more research is needed, barriers to research should be lifted and public health interests should be balanced with policies that support the industry.

Hahn replied that he believed there’s untapped therapeutic potential in the cannabis compound, but he also agreed that there are “unanswered questions that need to be filled in by data and science and research.”

In related developments, several consumer groups have recently expressed concerns about the current status of the CBD market.

Three groups—National Consumers League, Consumer Federation of America and Community Anti-Drug Coalitions of America—announced on Tuesday that they are launching an initiative called “Consumers for Safe CBD” that is designed to “warn the public of the potential risks related to CBD products.”

According to a press release, the coalition will also encourage FDA “to use its existing authority to protect consumers, provide guidance to manufacturers, and encourage further research for FDA-approved CBD treatments.”

Another group, the Consumer Healthcare Products Association (CHPA), launched a citizen petition to FDA last week that implores the agency to quickly develop rules for CBD so that the products can be lawfully marketed as dietary supplements.

“Intense consumer demand and commercial interest has resulted in a flood of CBD products of uncertain quality and unapproved claims already in the marketplace, and this scenario has created an urgent need for FDA action,” CHPA President Scott Melville said in a press release.

“The request in our petition seeks to have FDA utilize the authority it already has to establish a lawful regulatory pathway for manufacturers to bring dietary supplements containing CBD to market,” he said. “Only then will consumers be able to purchase CBD-containing dietary supplements in a manner that ensures product quality, safety, and a level-playing field for enforcement.”

Senators Push USDA To Adopt Five Changes To Proposed Hemp Regulations

Photo courtesy of Twitter/Senate Majority Leader.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Senators Push USDA To Adopt Five Changes To Proposed Hemp Regulations

Published

on

Sens. Ron Wyden (D-OR) and Jeff Merkley (D-OR) sent a letter to the head of the U.S. Department of Agriculture (USDA) on Wednesday, requesting a series of changes to draft rules for hemp that the department released last month.

The senators said they appreciate that USDA issued the proposed regulations, which is a “necessary step to establish a domestic federal hemp production program.” However, they wanted to highlight “several concerns about the unintended and potentially harmful effects this interim final rule would have on hemp production in Oregon and across the country.”

In the letter to Agriculture Sec. Sonny Perdue, they listed five issues with the regulations and suggested potential fixes. Many of the concerns echoed those that stakeholders have submitted to USDA as part of a public comment period the department launched on October 31. Here’s what the senators highlighted:

—As written, the draft rules call for hemp to be tested within 15 days before harvest. Farmers have argued that’s far too little time, and the senators said it presents an “impossible obstacle for growers to overcome.” Oregon regulations require testing within 28 days, so they said USDA should adopt a similar timeline.

—USDA said that testing must be completed at a laboratory registered with the Drug Enforcement Administration. The senators said that will produce a bottleneck and delays for hemp producers, and that independent laboratories such as those operating in Oregon should be allowed to conduct the tests.

—The senators said that USDA should allow for forms of THC concentration testing that do not involve post-decarboxylation and also argued that the congressional intent of hemp legalization was not to require testing of all THC compounds but rather just delta-9 THC in particular.

—USDA requires that testing samples come from the top one-third of the flower portion of the plant. Instead, the senators said, samples should follow established protocol in states like Oregon, which stipulates that samples should be taken from the flowering tops when they’re present and be eight inches long.

—While the Farm Bill defines hemp as cannabis containing no more than 0.3 percent THC on a dry weight basis, USDA gave slight margin of error and considers any plants with more than 0.5 percent THC to be in violation of the regulations. Farmers have called that limitation arbitrary and the senators said it would be more reasonable to set the negligence threshold at 1 percent, if there must be a THC restriction at all.

“Farmers in Oregon and across the country are on the precipice of an agricultural boom that, with the right regulatory framework, stands to boost rural economies in every corner of the country,” they wrote.

Wyden and Merkley have been some of the most vocal proponents of developing USDA regulations that bolster the hemp industry since the passage of the Farm Bill, through which they worked to legalize the crop in the first place. As early as February, Wyden and Senate Majority Leader Mitch McConnell (R-KY) were knocking at USDA’s door, urging the department to expedite the rulemaking process.

Read the full senators’ letter to USDA on hemp regulations below: 

Wyden Merkley USDA Hemp Rul… by Marijuana Moment on Scribd

GOP Senator Says He Tried CBD And Jokes About Its Hair Regrowth Potential

Photo courtesy of Brendan Cleak.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Virginia Attorney General Hosts ‘Cannabis Summit’ To Advance Reform In New Democratic Legislature

Published

on

Virginia’s attorney general is inviting state lawmakers to a “Cannabis Summit” next month as talk about advancing marijuana decriminalization and other reforms during the 2020 legislative session picks up.

Officials from other states that have legalized or decriminalized cannabis will speak at the event, as will academics who study the issue.

“This upcoming General Assembly Session policymakers will be considering legislation related to cannabis use in the Commonwealth,” an invitation states. “This summit is designed to better inform those discussions and offer perspectives from states that have implemented similar changes at the state level.”

“The summit will consist of 4 panels of experts from around the country to speak on the following topics related to cannabis policy: decriminalization of marijuana, social equity, regulating CBD & Hemp products, pathways towards legalization through legislative efforts and other topics that will better inform the upcoming legislative work,” reads the invitation sent out by the attorney general’s office, which was first reported by The Virginia Mercury.

Attorney General Mark Herring (D) said last month that the legislature will first move to pass a cannabis decriminalization bill—something that Gov. Ralph Northam (D) had campaigned on and talked about in his State of the State address.

Lawmakers will then “get to work on a larger study about how and when we could move toward legal and regulated adult use,” Herring said.

“Criminalizing marijuana possession is not working. It is needlessly creating criminals, saddling people with convictions and costing taxpayers millions each year,” the attorney general wrote in an op-ed for the Virginian-Pilot this week. “The social and human costs are tremendous, and the weight of the system falls disproportionately on African Americans and people of color. There are smarter, better ways we can handle cannabis and that begins with decriminalizing simple possession of small amounts, addressing past convictions and moving towards legal, regulated adult use.”

The chances of getting cannabis reform policies through the General Assembly significantly increased after this month’s election, which saw Democrats reclaim control of both chambers for the first time in decades.

Accordingly, a lawmaker prefiled a cannabis decriminalization bill this week that would make possession of up to one ounce of marijuana punishable by a maximum $50 civil penalty.

The announcement of the Cannabis Summit, which will take place in Richmond on December 11, is another signal that political support for reforming Virginia’s marijuana laws is strong. And while Northam has not endorsed adult-use legalization, the inclusion of that issue in panel discussions indicates that decriminalization is just the beginning of the conversation. Advocates are also pushing the state to expand its limited medical cannabis program.

“The attorney general’s public support for advancing evidence-based cannabis policy, coupled with the recent formation of the Virginia Cannabis Caucus, set the stage for a robust and unprecedented exploration of real-world experiences with decriminalization, legalization and regulation in other states,” Jenn Michelle Pedini, executive director of Virginia NORML, told The Virginia Mercury.

NORML honored Herring with its “Vanguard Award” as part of its national conference in September.

Rhode Island Governor Will Pursue Legal Marijuana In 2020

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!